Master in PHARMACEUTICAL BIOTECHNOLOGIES

Tuition fees are 2,890 EUR per year.

Pharmaceutical biotechnology examines how biological systems and living organisms are used to design, develop, and manufacture medicines and other therapeutic products. Students in this field typically study molecular biology, biochemistry, pharmacology, genetics, and industrial bioprocessing, alongside coursework on drug discovery, quality control, and regulatory affairs. The discipline bridges laboratory science and pharmaceutical production, preparing graduates to work on the biological mechanisms behind therapeutics such as vaccines, monoclonal antibodies, and recombinant proteins. Coursework often covers cell culture techniques, fermentation processes, and the validation methods used to bring biotech-derived drugs from bench to market. Graduates from programs in this area commonly pursue careers in pharmaceutical and biotechnology companies, research institutes, regulatory agencies, and quality assurance departments. Some continue toward doctoral research in molecular pharmacology or biomedical science, while others move into production management, clinical development support, or scientific consulting. This master's program in Pharmaceutical Biotechnologies is offered by Università degli Studi di Padova, located in Padova, Italy. It runs for two years and is taught in English, making it accessible to international students seeking postgraduate study in this field. Padova is home to one of Italy's oldest universities, situated in the Veneto region of northeastern Italy. Students considering this path generally arrive with an undergraduate background in biology, biotechnology, pharmacy, chemistry, or a related life science, since the master's level builds on foundational scientific training. The program's structure reflects the interdisciplinary nature of pharmaceutical biotechnology, combining laboratory-based learning with theoretical study of how biological products move from research through to therapeutic use.